article thumbnail

New product could aid successful production of mRNA therapeutics

Drug Discovery World

PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA production to less than 10%. We are thrilled to launch this enzyme which will remove both the technical and financial barriers to the successful production of mRNA therapeutics.”

article thumbnail

SLAS Europe reveals New Product Award finalists

Drug Discovery World

SLAS has announced the finalists for its New Product Award, with the winners to be announced at the annual conference. It will feature scientific sessions and keynote presentations, discussion groups, new product demonstrations and extensive exhibition access time.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How single-use technologies can improve antibodies production  

Drug Discovery World

Where the bottlenecks of achieving higher cell density and higher titers were once thought to be issues of the past, hurdles have now shifted to achieving speed and scale in mAb production without sacrificing quality. DC: Antibodies have and remain a large product class within the biopharmaceutical market.

article thumbnail

Biologic Product Hopping: Innovation or Market Manipulation?

Drug Patent Watch

As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […] Source

article thumbnail

Webinar: Environmental monitoring within biotherapeutic production

Drug Discovery World

Microbial control within biopharmaceutical manufacturing is a critical quality control to help ensure drug products are free from viable microorganisms. The post Webinar: Environmental monitoring within biotherapeutic production appeared first on Drug Discovery World (DDW).

article thumbnail

Webinar: Understand microbial control in biotherapy production

Drug Discovery World

Microbial control within biopharmaceutical manufacturing is a critical quality control to help ensure drug products are free from viable microorganisms. The post Webinar: Understand microbial control in biotherapy production appeared first on Drug Discovery World (DDW).

article thumbnail

Pioneering access to complex generic products 

Drug Discovery World

Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. Complex generics comprise a diverse range of products.